Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

The drug combination was safe and showed promise in treating advanced tumors.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Spironolactone might lower the chance of getting rosacea.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

The treatment combination is effective and generally safe for lung cancer.

Spironolactone effectively reduces symptoms of hyperandrogenism but has some side effects.

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Losartan may help treat Postural Orthostatic Tachycardia Syndrome (POTS) symptoms.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Compound 4 is a promising treatment for hair loss with low toxicity.

Deslorelin can help control reproduction and improve hair growth in German Spitz dogs.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Spironolactone effectively treats hormonal acne, hair loss, and excess hair growth in women.